Clinical Trial Update: Japanese BAY86-9766 Monotherapy Phase I Study [Phase 1]

View source ↗

Summary

Bayer's BAY86-9766 monotherapy Phase I trial in Japanese patients with neoplasms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasms

Drugs mentioned

• BAY86-9766

Snippet

Sponsor: Bayer | Conditions: Neoplasms | Phase 1 | Status: COMPLETED